Literature DB >> 3943321

Methodology to assess the oxygen concentration of red cells and stroma-free hemoglobin solutions.

A L Rosen, L R Sehgal, S A Gould, H L Sehgal, G S Moss.   

Abstract

Stroma-free hemoglobin (SFH) solution is an acellular oxygen carrier under development as a temporary red blood cell (rbc) substitute. SFH will be of value if it contributes to oxygen loading (delivery) and unloading (consumption). If there is no interaction between red cell hemoglobin and SFH, then the composite oxygen dissociation curve for whole blood (WB) can be written as: SWB = rSSFH + (1 - r) Srbc, where S is the fractional saturation, and r is the SFH/WB hemoglobin ratio. This composite whole-blood curve was compared with the calculated curve, and the root mean square difference was 0.9%. Direct and indirect methods of measuring oxygen concentration ([O2]) of whole blood or plasma were compared. The regression line was [O2]indirect = 0.995 [O2]direct + 0.07 (r = 0.995, N = 16, p less than .01). The adequacy of anaerobic separation of plasma was evaluated by measuring the changes in PO2 and PCO2. The PO2 increased by less than 2 torr and the PCO2 decreased by less than 1 torr during in vitro tests. Both the direct and indirect methodology yielded consistent [O2] values for each carrier.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943321     DOI: 10.1097/00003246-198602000-00016

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

Review 1.  Red cell substitutes: present status.

Authors:  L R Sehgal; H L Sehgal; S A Gould; A L Rosen; R DeWoskin; G S Moss
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

2.  Oxygen transport by a modified haemoglobin solution (PPSFH) in a dog model of acute anaemia following hypovolaemia.

Authors:  D Gilroy; W Odling-Smee
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

3.  The efficacy of polymerized pyridoxylated hemoglobin solution as an O2 carrier.

Authors:  S A Gould; L R Sehgal; A L Rosen; H L Sehgal; G S Moss
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.